- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05486962
Remote Monitoring of Surgical Patients Through VALIDIC
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We propose to assess the feasibility and outcomes of use of a wearable activity tracker for monitoring daily step counts in the peri-operative and 30 day post-operative period in elderly patients receiving elective abdominal surgery at Duke. We will use the information as guidance for improving activity in surgical patients at Duke. All ambulatory patients going through the POSH program currently receive individualized counseling on enhancing their activity levels. The data collected in this project will be used to help refine counseling and identify optimal time frames where exercise counseling is most beneficial. Our goal is to help with disease management, remote monitoring alerts, readmission prevention, care coordination and placement of required consults.
Aim1: Evaluate the feasibility of data capture, data integration into EPIC, and validate data flow Aim 2: Retrospective review of data to identify opportunities for alerts Aim 3: Improve physical function of older patients
This is a prospective remote patient monitoring study in the peri-operative and post-operative period to improve surgical outcomes. The peri-operative period starts at the time of the surgery/POSH clinic visit, continues during the inpatient hospital stay and for 30 days following discharge.
Patients undergoing elective abdominal surgery will be asked to use a wearable activity tracker, vivosmart®HR by Garmin, pre and post-operatively to help remotely monitor health metrics. Data collected through the Garmin device will be reviewed to assess compliance and improvement in activity. Aggregate data will be analyzed to assess feasibility and effectiveness of this device in improving patient recovery. The metrics we plan to assess are the following:
Garmin data:
Steps, distance, calories, heart rate, 7 day resting average, floors climbed activity intensity, sleep cycles, inactive periods.
Surgery data:
Length of stay, Complications, Readmissions, Emergency Department visits
Patients may be called weekly to ensure compliance and ask any questions or report any issues with the activity tracker. All data will exist in MaestroCare and will be captured after the post-surgical period.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Over 75 yo
- HBP procedures, Colorectal procedures, Open VHRs
- No obvious cognitive deficits
- Should be able to walk with or without mobility aid
- Willingness to use smart phone in the study
Exclusion Criteria:
- non-ambulatory status,
- dementia, or
- a pending cardiac clearance requirement for surgery.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Remote Patient Monitoring
Patients undergoing elective abdominal surgery will be asked to use a wearable activity tracker, vivosmart®HR by Garmin, pre and post-operatively to help remotely monitor health metrics.
Data collected through the Garmin device will be reviewed to assess compliance and improvement in activity.
Aggregate data will be analyzed to assess feasibility and effectiveness of this device in improving patient recovery.
|
Patients undergoing elective abdominal surgery will be asked to use a wearable activity tracker, vivosmart®HR by Garmin, pre and post-operatively to help remotely monitor health metrics.
Data collected through the Garmin device will be reviewed to assess compliance and improvement in activity.
Aggregate data will be analyzed to assess feasibility and effectiveness of this device in improving patient recovery.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment Rate
Time Frame: Enrollment
|
proportion of those who were approached and eligible, and who agreed to participate (i.e., recruitment rates)
|
Enrollment
|
|
Completion Rate
Time Frame: 30 days post-operatively
|
proportion of those who completed the protocol (i.e., completion rate)
|
30 days post-operatively
|
|
Retention Rate
Time Frame: 30 days post-operatively
|
proportion who participated in all three settings (pre hospital, hospital, post hospital) (i.e., retention rate),
|
30 days post-operatively
|
|
Scale-Level Completion Rate
Time Frame: 30 days post-operatively
|
proportion who completed use of the activity trackers, and determine the reason for any missing data including lack of understanding, ability, or simple refusal (i.e., scale-level completion rate);
|
30 days post-operatively
|
|
Study Duration
Time Frame: 45 days after last patient enrollment
|
documented duration of the protocol (i.e., feasibility);
|
45 days after last patient enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alert Timepoints
Time Frame: 30 days post-operatively
|
Retrospective review of data to identify opportunities for alerts: LOS, Complications, Readmissions, ED visits |
30 days post-operatively
|
|
Physical Function
Time Frame: 30 days post-operatively
|
Improve physical function of older patients by evaluating: LOS, Complications, Readmissions, ED visits |
30 days post-operatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sandhya Lagoo-Deenadayalan, MD, PhD, Duke Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00110616
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elective Abdominal Surgery
-
Indonesia UniversityRecruitingElective Major Abdominal SurgeryIndonesia
-
Mansoura UniversityCompletedElective Major Abdominal SurgeryEgypt
-
Mansoura UniversityCompleted
-
Poznan University of Medical SciencesRecruitingElective Endovascular Abdominal Aortic Surgery With an Expected Surgical Duration Exceeding 2 Hours | Elective Open Abdominal Aortic Surgery With an Expected Surgical Duration Exceeding 2 HoursPoland
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingElective Major Abdominal SurgeryChina
-
CHU de ReimsUnknownPatients Ongoing Elective Abdominal LaparoscopyFrance
-
Tongji HospitalCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingMajor Elective Abdominal and Thoracic SurgerySpain
-
Washington University School of MedicineActive, not recruiting
-
Nanjing Medical UniversityCompleted
Clinical Trials on Remote Patient Monitoring
-
Northwestern UniversityOmron Healthcare Co., Ltd.Completed
-
University of Mississippi Medical CenterHealth Resources and Services Administration (HRSA)Completed
-
University of British ColumbiaCompleted
-
Charite University, Berlin, GermanyCompletedRemote Patient Monitoring on Intensive Care UnitGermany
-
University of California, DavisCompletedType 1 DiabetesUnited States
-
Columbia UniversityNew York Presbyterian Hospital; Philips HealthcareCompleted
-
Tracy Jalbuena MDHealth Resources and Services Administration (HRSA); MaineHealthWithdrawnDiabetes Mellitus, Type 2United States
-
Massachusetts General HospitalWithdrawnGastrointestinal Cancer
-
AION BiosystemsEllis MedicineRecruitingCancer | Fever | Remote Patient MonitoringUnited States
-
Centre Hospitalier de BlignyCureety; Exystat; Pharmaspecific; ProPensCompleted